1. Home
  2. VTAK vs WLGS Comparison

VTAK vs WLGS Comparison

Compare VTAK & WLGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTAK
  • WLGS
  • Stock Information
  • Founded
  • VTAK 2002
  • WLGS 1981
  • Country
  • VTAK United States
  • WLGS Hong Kong
  • Employees
  • VTAK N/A
  • WLGS N/A
  • Industry
  • VTAK Medical/Dental Instruments
  • WLGS Engineering & Construction
  • Sector
  • VTAK Health Care
  • WLGS Consumer Discretionary
  • Exchange
  • VTAK Nasdaq
  • WLGS Nasdaq
  • Market Cap
  • VTAK 3.1M
  • WLGS 3.0M
  • IPO Year
  • VTAK 2018
  • WLGS 2023
  • Fundamental
  • Price
  • VTAK $0.17
  • WLGS $0.04
  • Analyst Decision
  • VTAK
  • WLGS
  • Analyst Count
  • VTAK 0
  • WLGS 0
  • Target Price
  • VTAK N/A
  • WLGS N/A
  • AVG Volume (30 Days)
  • VTAK 1.9M
  • WLGS 133.2M
  • Earning Date
  • VTAK 08-13-2025
  • WLGS 08-14-2025
  • Dividend Yield
  • VTAK N/A
  • WLGS N/A
  • EPS Growth
  • VTAK N/A
  • WLGS N/A
  • EPS
  • VTAK N/A
  • WLGS N/A
  • Revenue
  • VTAK $481,000.00
  • WLGS $3,951,649.00
  • Revenue This Year
  • VTAK $822.86
  • WLGS N/A
  • Revenue Next Year
  • VTAK $168.42
  • WLGS N/A
  • P/E Ratio
  • VTAK N/A
  • WLGS N/A
  • Revenue Growth
  • VTAK 9.57
  • WLGS N/A
  • 52 Week Low
  • VTAK $0.15
  • WLGS $0.03
  • 52 Week High
  • VTAK $2.49
  • WLGS $9.66
  • Technical
  • Relative Strength Index (RSI)
  • VTAK 31.31
  • WLGS 42.68
  • Support Level
  • VTAK $0.20
  • WLGS $0.04
  • Resistance Level
  • VTAK $0.24
  • WLGS $0.07
  • Average True Range (ATR)
  • VTAK 0.02
  • WLGS 0.02
  • MACD
  • VTAK -0.01
  • WLGS 0.01
  • Stochastic Oscillator
  • VTAK 4.13
  • WLGS 11.13

About VTAK Catheter Precision Inc.

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

About WLGS Wang & Lee Group Inc.

WANG & LEE Group Inc operates as an investment holding company. The firm conducts its primary operations through its indirectly wholly owned subsidiary WANG and LEE CONTRACTING LIMITED. WLHK provides contract engineering, installation, and out-fitting of the following products and services: low voltage electrical systems, mechanical ventilation and air-conditioning systems (MVAC), fire safety systems, water supply and sewage disposal systems, and site project management.

Share on Social Networks: